- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AC-1204
Total 1163 results
-
RVL Pharmaceuticals, Inc.CompletedAcquired BlepharoptosisUnited States
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
RVL Pharmaceuticals, Inc.CompletedBlepharoptosisUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnProstate CancerUnited States
-
Agios Pharmaceuticals, Inc.Approved for marketingAcute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
-
Dr. Reddy's Laboratories LimitedCompleted
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
MedImmune LLCCompletedCardiovascular Disease | AtherosclerosisUnited States
-
Heidelberg Pharma AGCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Jena University HospitalGE HealthcareUnknownThyroid Diseases | Thyroid Nodule | Thyroid GoitreGermany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Fibrolamellar Cancer Foundation; Dracen Pharmaceuticals, Inc.RecruitingFibrolamellar Hepatocellular CarcinomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenIpsenCompletedPolycystic Liver DiseaseBelgium
-
Oslo University HospitalTakeda Nycomed; Sykehuset Asker og BaerumCompleted
-
M.D. Anderson Cancer CenterWithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8
-
BrightPath BiotherapeuticsTerminated
-
Tanta UniversityCompleted
-
Cairo UniversityUnknownCoronary Artery Disease, Early-OnsetOman
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
TG Therapeutics, Inc.Terminated
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
CelgeneCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Chronic Myelomonocytic Leukemia-0United States
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
National Institute of Allergy and Infectious Diseases...Completed
-
Ocera TherapeuticsCompletedHepatic EncephalopathyUnited States
-
Aziende Chimiche Riunite Angelini Francesco S.p.ACross S.A.Completed
-
Vifor (International) Inc.FortreaCompletedSickle Cell DiseaseUnited States, France, Greece, Lebanon, United Kingdom
-
Novo Nordisk A/SCompleted
-
Massachusetts General HospitalTG TherapeuticsTerminatedLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
Hospital Severo OchoaInstituto de Salud Carlos IIICompleted
-
Novartis PharmaceuticalsRecruitingFood AllergySpain, France, Germany, Italy, United States, Netherlands, Canada, Japan, Australia
-
Leiden University Medical CenterRecruitingDifferentiated Thyroid CancerNetherlands
-
Almirall, S.A.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, PulmonaryUnited States
-
TikoMed ABRecruitingDiabetes Mellitus, Type 1Sweden, Norway, Netherlands
-
Groupe Francophone des MyelodysplasiesActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance, Italy
-
Sangamo TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States
-
Agios Pharmaceuticals, Inc.Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingRecurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States